AQR Capital Management’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.82M | Sell |
279,850
-338,777
| -55% | -$2.2M | ﹤0.01% | 1836 |
|
|
2025
Q1 | $4.91M | Buy |
618,627
+530,429
| +601% | +$4.21M | 0.01% | 1132 |
|
|
2024
Q4 | $1.12M | Sell |
88,198
-42,112
| -32% | -$534K | ﹤0.01% | 1830 |
|
|
2024
Q3 | $1.82M | Buy |
130,310
+17,290
| +15% | +$241K | ﹤0.01% | 1553 |
|
|
2024
Q2 | $1.56M | Buy |
113,020
+94,703
| +517% | +$1.31M | ﹤0.01% | 1564 |
|
|
2024
Q1 | $303K | Buy |
18,317
+8,159
| +80% | +$135K | ﹤0.01% | 2130 |
|
|
2023
Q4 | $148K | Buy |
+10,158
| New | +$148K | ﹤0.01% | 2251 |
|
|
2023
Q3 | – | Sell |
-14,404
| Closed | -$172K | – | 2329 |
|
|
2023
Q2 | $172K | Buy |
14,404
+1,348
| +10% | +$16.1K | ﹤0.01% | 2099 |
|
|
2023
Q1 | $175K | Buy |
13,056
+3,545
| +37% | +$47.4K | ﹤0.01% | 2071 |
|
|
2022
Q4 | $205K | Buy |
+9,511
| New | +$205K | ﹤0.01% | 2076 |
|